Skip to main content
Top
Published in: Tumor Biology 4/2015

01-04-2015 | Research Article

Investigation of the role of 8-OHdG and oxidative stress in papillary thyroid carcinoma

Authors: Suzan Tabur, Şefika Nur Aksoy, Hakan Korkmaz, Mesut Ozkaya, Nurten Aksoy, Ersin Akarsu

Published in: Tumor Biology | Issue 4/2015

Login to get access

Abstract

The aim of this study was to determine levels of serum 8-hydroxy-2′-deoxyguanosine (8-OHdG) as an indicator of oxidant-induced DNA damage and oxidant status in patients with papillary thyroid carcinoma before and after surgery. This study included 25 patients with papillary thyroid carcinoma and age-matched 27 healthy controls. Total antioxidant status (TAS), total oxidant status (TOS), lipid hydroperoxide (LOOH), and 8-OHdG levels were measured. 8-OHdG levels were significantly higher in the preoperative papillary thyroid carcinoma (PTC) group compared with the healthy control group (p < 0.001) and were significantly lower after operation in patients with papillary thyroid carcinoma (p = 0.004). Oxidative stress index (OSI) levels were significantly higher in both preoperative and postoperative PTC patients compared with the healthy control group (p < 0.001 and p < 0.001, respectively). TOS levels were higher in the preoperative and postoperative PTC groups compared to the healthy control group (p < 0.001 and p < 0.001, respectively). TAS levels was lower in the preoperative PTC groups compared to the healthy control group (p = 0.011). Serum LOOH levels were higher in both preoperative and postoperative PTC groups compared to the healthy control group (p < 0.001 and p < 0.001, respectively). Correlation analysis yielded that serum 8-OHdG levels were positively correlated with OSİ and LOOH levels in patients with PTC before surgery (r = 0.668, p < 0.001; r = 0.446, p = 0.025, respectively) and had a negative correlation with TAS levels (r = −0.616, p = 0.001). We have shown severe oxidative DNA damage and impaired antioxidant status in papillary thyroid carcinoma.
Literature
1.
go back to reference Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.CrossRefPubMed Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.CrossRefPubMed
2.
go back to reference Sprague BL, Warren AS, Trentham-Dietz A. Thyroid cancer incidence and socioeconomic indicators of health care access. Cancer Cases Control. 2008;19:585–93.CrossRef Sprague BL, Warren AS, Trentham-Dietz A. Thyroid cancer incidence and socioeconomic indicators of health care access. Cancer Cases Control. 2008;19:585–93.CrossRef
3.
4.
go back to reference Chan AC, Lang BH, Wong KP. The pros and cons of routine central compartment neck dissection for clinically nodal negative (cN0) papillary thyroid cancer. Gland Surg. 2013;2(4):186–95.PubMedPubMedCentral Chan AC, Lang BH, Wong KP. The pros and cons of routine central compartment neck dissection for clinically nodal negative (cN0) papillary thyroid cancer. Gland Surg. 2013;2(4):186–95.PubMedPubMedCentral
5.
go back to reference Maier J, van Steeg H, van Oostrom C, Karger S, Paschke R, Krohn K. Deoxyribonucleic acid damage and spontaneous mutagenesis in the thyroid gland of rats and mice. Endocrinology. 2006;147(7):3391–7.CrossRefPubMed Maier J, van Steeg H, van Oostrom C, Karger S, Paschke R, Krohn K. Deoxyribonucleic acid damage and spontaneous mutagenesis in the thyroid gland of rats and mice. Endocrinology. 2006;147(7):3391–7.CrossRefPubMed
6.
go back to reference Beckman RA, Loeb LA. Genetic instability in cancer: theory and experiment. Semin Cancer Biol. 2005;15(6):423–35.CrossRefPubMed Beckman RA, Loeb LA. Genetic instability in cancer: theory and experiment. Semin Cancer Biol. 2005;15(6):423–35.CrossRefPubMed
7.
9.
go back to reference Valko M, Izakovic M, Mazur M, Rhodes CJ, Telser J. Role of oxygen radicals in DNA damage and cancer incidence. Mol Cell Biochem. 2004;266(1–2):37–56.CrossRefPubMed Valko M, Izakovic M, Mazur M, Rhodes CJ, Telser J. Role of oxygen radicals in DNA damage and cancer incidence. Mol Cell Biochem. 2004;266(1–2):37–56.CrossRefPubMed
10.
go back to reference Chow E, Thirlwell C, Macrae F, Lipton L. Colorectal cancer and inherited mutations in base-excision repair. Lancet Oncol. 2004;5(10):600–6.CrossRefPubMed Chow E, Thirlwell C, Macrae F, Lipton L. Colorectal cancer and inherited mutations in base-excision repair. Lancet Oncol. 2004;5(10):600–6.CrossRefPubMed
11.
go back to reference Himmetoglu S, Dincer Y, Ersoy YE, Bayraktar B, Celik V, Akcay T. DNA oxidation and antioxidant status in breast cancer. J Investig Med. 2009;57(6):720–3.CrossRefPubMed Himmetoglu S, Dincer Y, Ersoy YE, Bayraktar B, Celik V, Akcay T. DNA oxidation and antioxidant status in breast cancer. J Investig Med. 2009;57(6):720–3.CrossRefPubMed
12.
go back to reference Arsova-Sarafinovska Z, Eken A, Matevska N, Erdem O, Sayal A, Savaser A, et al. Increased oxidative/nitrosative stress and decreased antioxidant enzyme activities in prostate cancer. Clin Biochem. 2009;42(12):1228–35.CrossRefPubMed Arsova-Sarafinovska Z, Eken A, Matevska N, Erdem O, Sayal A, Savaser A, et al. Increased oxidative/nitrosative stress and decreased antioxidant enzyme activities in prostate cancer. Clin Biochem. 2009;42(12):1228–35.CrossRefPubMed
13.
go back to reference Gönenç A, Hacışevki A, Aslan S, Torun M, Şimşek B. Increased oxidative DNA damage and impaired antioxidant defense system in patients with gastrointestinal cancer. Eur J Intern Med. 2012;23(4):350–4.CrossRefPubMed Gönenç A, Hacışevki A, Aslan S, Torun M, Şimşek B. Increased oxidative DNA damage and impaired antioxidant defense system in patients with gastrointestinal cancer. Eur J Intern Med. 2012;23(4):350–4.CrossRefPubMed
14.
go back to reference Bulut M, Selek S, Bez Y, Karababa IF, Kaya MC, Gunes M, et al. Reduced PON1 enzymatic activity and increased lipid hydroperoxide levels that point out oxidative stress in generalized anxiety disorder. J Affect Disord. 2013;150(3):829–33.CrossRefPubMed Bulut M, Selek S, Bez Y, Karababa IF, Kaya MC, Gunes M, et al. Reduced PON1 enzymatic activity and increased lipid hydroperoxide levels that point out oxidative stress in generalized anxiety disorder. J Affect Disord. 2013;150(3):829–33.CrossRefPubMed
15.
go back to reference Girotti AW. Lipid hydroperoxide generation, turnover, and effector action in biological systems. J Lipid Res. 1998;39(8):1529–42.PubMed Girotti AW. Lipid hydroperoxide generation, turnover, and effector action in biological systems. J Lipid Res. 1998;39(8):1529–42.PubMed
16.
go back to reference Sherman SI, Brierley JD, Sperling M, Ain KB, Bigos ST, Cooper DS, et al. Prospective multicenter study of thyroiscarcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group. Cancer. 1998;83(5):1012–21.CrossRefPubMed Sherman SI, Brierley JD, Sperling M, Ain KB, Bigos ST, Cooper DS, et al. Prospective multicenter study of thyroiscarcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group. Cancer. 1998;83(5):1012–21.CrossRefPubMed
17.
go back to reference Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem. 2005;38(12):1103–11.CrossRefPubMed Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem. 2005;38(12):1103–11.CrossRefPubMed
18.
go back to reference Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem. 2004;37(2):112–9.CrossRefPubMed Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem. 2004;37(2):112–9.CrossRefPubMed
19.
go back to reference Arab K, Steghens JP. Serum lipid hydroperoxides measurement by an automated xylenol orange method. Anal Biochem. 2004;325:158–63.CrossRefPubMed Arab K, Steghens JP. Serum lipid hydroperoxides measurement by an automated xylenol orange method. Anal Biochem. 2004;325:158–63.CrossRefPubMed
20.
go back to reference Aycicek A, Erel O, Kocyigit A. Increased oxidative stress in infants exposed to passive smoking. Eur J Pediatr. 2005;164:775–8.CrossRefPubMed Aycicek A, Erel O, Kocyigit A. Increased oxidative stress in infants exposed to passive smoking. Eur J Pediatr. 2005;164:775–8.CrossRefPubMed
21.
go back to reference Nourooz-Zadeh J. Ferrous ion oxidation in presence of xylenol orange for detection of lipid hydroperoxides in plasma. Methods Enzymol. 1999;300:58–62.CrossRefPubMed Nourooz-Zadeh J. Ferrous ion oxidation in presence of xylenol orange for detection of lipid hydroperoxides in plasma. Methods Enzymol. 1999;300:58–62.CrossRefPubMed
22.
go back to reference Ceylan MF, Guney E, Alisik M, Ergin M, Dinc GS, Goker Z, et al. Lipid peroxidation markers in children with anxiety disorders and their diagnostic implications. Redox Rep. 2014;19(2):92–6.CrossRefPubMed Ceylan MF, Guney E, Alisik M, Ergin M, Dinc GS, Goker Z, et al. Lipid peroxidation markers in children with anxiety disorders and their diagnostic implications. Redox Rep. 2014;19(2):92–6.CrossRefPubMed
23.
go back to reference Pande D, Negi R, Karki K, Khanna S, Khanna RS, Khanna HD. Oxidative damage markers as possible discriminatory biomarkers in breast carcinoma. Transl Res. 2012;160(6):411–8. Pande D, Negi R, Karki K, Khanna S, Khanna RS, Khanna HD. Oxidative damage markers as possible discriminatory biomarkers in breast carcinoma. Transl Res. 2012;160(6):411–8. 
24.
go back to reference Diakowska D, Lewandowski A, Kopeć W, Diakowski W, Chrzanowska T. Oxidative DNA damage and total antioxidant status in serum of patients with esophageal squamous cell carcinoma. Hepatogastroenterology. 2007;54(78):1701–4.PubMed Diakowska D, Lewandowski A, Kopeć W, Diakowski W, Chrzanowska T. Oxidative DNA damage and total antioxidant status in serum of patients with esophageal squamous cell carcinoma. Hepatogastroenterology. 2007;54(78):1701–4.PubMed
25.
go back to reference Pande D, Negi R, Karki K, Khanna S, Khanna RS, Khanna HD. Oxidative damage markers as possible discriminatory biomarkers in breast carcinoma. Transl Res. 2012;160(6):411–8.CrossRefPubMed Pande D, Negi R, Karki K, Khanna S, Khanna RS, Khanna HD. Oxidative damage markers as possible discriminatory biomarkers in breast carcinoma. Transl Res. 2012;160(6):411–8.CrossRefPubMed
26.
go back to reference Płachetka A, Adamek B, Strzelczyk JK, Krakowczyk Ł, Migula P, Nowak P, et al. 8-Hydroxy-2′-deoxyguanosine in colorectal adenocarcinoma—is it a result of oxidative stress? Med Sci Monit. 2013;21(19):690–5. Płachetka A, Adamek B, Strzelczyk JK, Krakowczyk Ł, Migula P, Nowak P, et al. 8-Hydroxy-2′-deoxyguanosine in colorectal adenocarcinoma—is it a result of oxidative stress? Med Sci Monit. 2013;21(19):690–5.
27.
go back to reference Kosova F, Temeltaş G, Arı Z, Lekili M. Possible relations between oxidative damage and apoptosis in benign prostate hyperplasia and prostate cancer patients. Tumour Biol. 2014;35(5):4295–9.CrossRefPubMed Kosova F, Temeltaş G, Arı Z, Lekili M. Possible relations between oxidative damage and apoptosis in benign prostate hyperplasia and prostate cancer patients. Tumour Biol. 2014;35(5):4295–9.CrossRefPubMed
28.
go back to reference Young O, Crotty T, O’Connell R, O’Sullivan J, Curran AJ. Levels of oxidative damage and lipid peroxidation in thyroid neoplasia. Head Neck. 2010;32(6):750–6.PubMed Young O, Crotty T, O’Connell R, O’Sullivan J, Curran AJ. Levels of oxidative damage and lipid peroxidation in thyroid neoplasia. Head Neck. 2010;32(6):750–6.PubMed
29.
go back to reference Sharma A, Rajappa M, Saxena A, Sharma M. Antioxidant status in advanced cervical cancer patients undergoing neoadjuvant chemoradiation. Br J Biomed Sci. 2007;64(1):23–7.CrossRefPubMed Sharma A, Rajappa M, Saxena A, Sharma M. Antioxidant status in advanced cervical cancer patients undergoing neoadjuvant chemoradiation. Br J Biomed Sci. 2007;64(1):23–7.CrossRefPubMed
30.
go back to reference Karki K, Pande D, Negi R, Khanna S, Khanna RS, Khanna HD. Expression of serum toll-like receptor 9 and oxidative damage markers in benign and malignant breast diseases. DNA Cell Biol. 2014;33(9):630–6.CrossRefPubMed Karki K, Pande D, Negi R, Khanna S, Khanna RS, Khanna HD. Expression of serum toll-like receptor 9 and oxidative damage markers in benign and malignant breast diseases. DNA Cell Biol. 2014;33(9):630–6.CrossRefPubMed
Metadata
Title
Investigation of the role of 8-OHdG and oxidative stress in papillary thyroid carcinoma
Authors
Suzan Tabur
Şefika Nur Aksoy
Hakan Korkmaz
Mesut Ozkaya
Nurten Aksoy
Ersin Akarsu
Publication date
01-04-2015
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 4/2015
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-014-2889-6

Other articles of this Issue 4/2015

Tumor Biology 4/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine